Showing results (221-230 of 247) with videos related to
Sort By:
Pageof 25
Journal for Immunotherapy of Cancer|October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumorsLi Zhu, Jessica L Narloch, Sayali Onkar, et al.Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative StudiesNeil Carleton, Alexander C Chang, Fangyuan Chen, et al.Biorxiv : the Preprint Server for Biology|March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinomaNilgun Tasdemir, Laura Savariau, Julie Scott, et al.Science Translational Medicine|March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerThushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative StudiesNeil Carleton, Alexander C Chang, Fangyuan Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.Oncogene|January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotypeDamir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.NPJ Breast Cancer|June 21, 2025
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer researchHillary S Andrews, Igor L Bado, Amy Beumer, et al.Pageof 25